Possible Side Effects Epithalon is generally well-tolerated in preclinical and limited human observational studies
It is not approved as a drug, supplement, or food ingredient in the US, EU, Australia, and similar markets
ISO/IEC 17025-Accredited Laboratory Release Release decisions move to a third-party laboratory holding ISO/IEC 17025 accreditation, operating under separate management from the synthesis facility
DSIP as a modulator of the human central nervous system
Overall, this data suggests that even without definitive clinical proof of regrowth, copper peptides may be beneficial to your scalp and hair by helping create a more stable scalp environment, which is increasingly linked to the balance of microorganisms that live on the skin